Inovio Pharmaceuticals INO reported its Q4 earnings results on Wednesday, March 6, 2024 at 06:30 AM.
Here's what investors need to know about the announcement.
Earnings
Inovio Pharmaceuticals beat estimated earnings by 13.0%, reporting an EPS of $-1.1 versus an estimate of $-1.27.
Revenue was down $22 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 4.0% drop in the share price the next day.
Here's a look at Inovio Pharmaceuticals's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | -1.56 | -1.68 | -1.68 | -2.04 |
EPS Actual | -1.56 | -1.56 | -1.92 | -2.64 |
Revenue Estimate | 120K | 260K | 270K | 340K |
Revenue Actual | 388K | 225K | 114K | 125K |
To track all earnings releases for Inovio Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.